Reports for BAXTER CORPORATION
Company Name
BAXTER CORPORATION
Totals |
||
Shortage reports |
197 |
|
| Actual shortage: | 7 (4%) | |
| Anticipated shortage: | 1 (1%) | |
| Avoided shortage: | 3 (2%) | |
| Resolved: | 186 (94%) | |
Discontinuation Reports |
26 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 26 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
11 (5%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DOPAMINE HCL 3.2MG/ML DEXTROSE 5% INJ USP | 50MG 3.2MG | SOLUTION | Resolved | 2022-10-04 | 2022-12-01 | 171105 |
| 0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION | 50MG 4MG | SOLUTION | Resolved | 2019-10-04 | 2019-11-19 | 95574 |
| 0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION | 50MG 4MG | SOLUTION | Resolved | 2019-12-19 | 2020-01-28 | 101629 |
| 0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION | 50MG 4MG | SOLUTION SOLUTION | Resolved | 2023-01-05 | 2023-02-14 | 179915 |
| PROCYTOX TAB 50MG | 50MG | TABLET | Resolved | 2022-02-25 | 2022-04-14 | 155663 |
| CLINIMIX E | 520MG 24MG 58.5MG 261MG 205MG 20MG 210MG 90MG 210MG 220MG 230MG 240MG 1.04G 1.04G 290MG 290MG 310MG 310MG 16.6G | SOLUTION | Resolved | 2021-09-07 | 2021-11-26 | 145274 |
| PLASMA-LYTE A INJECTION | 526MG 368MG 502MG 37MG 30MG | SOLUTION | Resolved | 2020-08-17 | 2020-09-01 | 122375 |
| PLASMA-LYTE A INJECTION | 526MG 368MG 502MG 37MG 30MG | SOLUTION | Resolved | 2020-08-17 | 2020-08-18 | 122377 |
| NUTRINEAL PD4 | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | LIQUID | Resolved | 2018-05-23 | 2018-06-22 | 50095 |
| NUTRINEAL PD4 | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | LIQUID | Resolved | 2018-11-22 | 2019-02-27 | 67436 |
| CLINIMIX E | 58.5MG 261MG 205MG 20MG 210MG 90MG 210MG 220MG 230MG 240MG 520MG 1.04G 290MG 290MG 310MG 310MG 10G 1.04G 24MG | SOLUTION | Resolved | 2021-09-07 | 2021-10-25 | 145271 |
| (20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP | 5G 150MG 450MG | SOLUTION | Resolved | 2019-02-08 | 2019-02-13 | 75200 |
| NITROGLYCERIN IN 5% DEXTROSE INJ.-200MCG/ML | 5G 20MG | SOLUTION | Resolved | 2019-03-01 | 2019-03-19 | 77245 |
| POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR | 5G 300MG 900MG | SOLUTION | Resolved | 2017-05-04 | 2017-09-26 | 9057 |
| NITROGLYCERIN IN 5% DEXTROSE INJ.-400MCG/ML | 5G 40MG | SOLUTION | Resolved | 2019-05-01 | 2019-05-22 | 82898 |
| 5% DEXTROSE INJECTION, USP | 5G | LIQUID | Resolved | 2017-08-15 | 2018-03-01 | 19398 |
| 5% DEXTROSE INJECTION, USP | 5G | LIQUID | Resolved | 2017-10-17 | 2018-11-27 | 26118 |
| 5% DEXTROSE INJECTION, USP | 5G | LIQUID | Resolved | 2017-12-08 | 2018-11-27 | 32181 |
| 5% DEXTROSE INJECTION, USP | 5G | LIQUID | Resolved | 2018-01-03 | 2018-03-01 | 34771 |
| 5% DEXTROSE INJECTION, USP | 5G | LIQUID | Resolved | 2018-07-30 | 2018-10-10 | 56909 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACID CONCENTRATE 2125 | 89.99G 8.11G 3.21G 7.74G 3.35G 268.24G | SOLUTION | Discontinued | 2017-04-19 | 2017-12-22 | 7240 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | SOLUTION | Discontinued | 2020-07-23 | 2020-07-23 | 120952 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | SOLUTION | Discontinued | 2020-07-23 | 2020-07-23 | 120955 |
| ACID CONCENTRATE D12304 | 90G 10.8G 1.61G 7.48G 263G | SOLUTION | Discontinued | 2017-04-19 | 2017-12-22 | 7264 |
| ACID CONCENTRATE 2163 | 90G 10.8G 2.14G 6.24G 10.06G 275G | SOLUTION | Discontinued | 2017-04-19 | 2017-12-22 | 7249 |
| CLINIMIX E | 90MG 210MG 20MG 261MG 58.5MG 24MG 205MG 20G 310MG 310MG 290MG 290MG 1.04G 1.04G 520MG 240MG 230MG 220MG 210MG | SOLUTION | Discontinued | 2020-06-22 | 2021-03-26 | 118604 |